new glp-1 weight loss The U.S. Food and Drug Administration approved Eli Lilly's pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for weight-loss medications GLP-1 Weight Loss Medication |

Currently, Ozempic remains solely FDA-approved for Type 2 Diabetes, while Wegovy is FDA-approved for chronic weight management

A Science-Backed Solution for Sustainable Weight Loss Semaglutide is a GLP-1 receptor agonist , originally developed to manage type 2 diabetes, that has been found highly effective for supporting weight loss

The FDA's general position is that compounded drugs should be considered when a patient's medical needs cannot be met by an FDA-approved drug

Valdecantos MP, Pardo V, Ruiz L, Castro-Sanchez L, Lanzon B, Fernandez-Millan E, et al

But it can be an avenue for people who are struggling to get to that next step. This article originally appeared as A Balanced Approach to Weight-Loss Drugs in the March/April 2025 issue of Experience Life.